RJF — Laboratorio Reig Jofre SA Share Price
0.000.00%
Last trade - 00:00- €233.77m
- €269.28m
- €338.90m
- 84
- 49
- 75
- 84
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.26 | ||
| PEG Ratio (f) | 1.53 | ||
| EPS Growth (f) | 11.88% | ||
| Dividend Yield (f) | 1.13% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.09 | ||
| Price to Tang. Book | 1.77 | ||
| Price to Free Cashflow | 22.14 | ||
| Price to Sales | 0.69 | ||
| EV to EBITDA | 7.49 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.8% | ||
| Return on Equity | 4.96% | ||
| Operating Margin | 3.72% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 230.08 | 236.23 | 271.15 | 316.09 | 338.89 | 369.94 | 396.18 | 11.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +9.25 | +183.64 | -46.78 | +21.66 | +12.35 | +8.96 | +17.65 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
Directors
- Isabel Reig Lopez CHM
- Ignasi Biosca Reig CEO
- Alejandro Garcia Reig VCH
- Roser Gomila Zabala CFO
- Gabriel Roig Zapatero COO
- Antonio Ballesteros Gomez OTH
- Alain Boutboul OTH
- Ignacio Vila Rocafort OTH
- Adolf Rousaud Vinas SEC
- Anton Costas Comesana IND
- Maria Luisa Francoli Plaza IND
- Ramon Gomis I de Barbara IND
- Ramiro Martinez-Pardo del Valle IND
- Emilio Moraleda Martinez IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 1st, 1970
- Public Since
- November 7th, 2006
- No. of Employees
- 1,419
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Madrid Stock Exchange
- Shares in Issue
- 80,057,011
- Address
- Gran Capita, 10, SANT JOAN DESPI, 08970
- Web
- https://reigjofre.com/es/
- Phone
- +34 934806710
- Auditors
- KPMG Auditores, SL
Upcoming Events for RJF
Q2 2025 Laboratorio Reig Jofre SA Earnings Release
Similar to RJF
Almirall SA
Madrid Stock Exchange
Faes Farma SA
Madrid Stock Exchange
Grifols SA
Madrid Stock Exchange
Natac Natural Ingredients SA
Madrid Stock Exchange
Labiana Health SA
Madrid Stock Exchange
FAQ
What is the Laboratorio Reig Jofre SA share price?
As of Today at 21:41 UTC, shares in Laboratorio Reig Jofre SA are trading at €2.92. This share price information is delayed by 15 minutes.
How has the Laboratorio Reig Jofre SA share price performed this year?
Shares in Laboratorio Reig Jofre SA last closed at €2.92 and the price had moved by +17.74% over the past 365 days. In terms of relative price strength the Laboratorio Reig Jofre SA share price has outperformed the FTSE Global All Cap Index by +14.79% over the past year.
What are the analyst and broker recommendations for Laboratorio Reig Jofre SA?
The overall consensus recommendation for Laboratorio Reig Jofre SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Laboratorio Reig Jofre SA dividend yield?
Laboratorio Reig Jofre SA does not currently pay a dividend.
Does Laboratorio Reig Jofre SA pay a dividend?
Laboratorio Reig Jofre SA does not currently pay a dividend.
When does Laboratorio Reig Jofre SA next pay dividends?
Laboratorio Reig Jofre SA does not currently pay a dividend.
How do I buy Laboratorio Reig Jofre SA shares?
To buy shares in Laboratorio Reig Jofre SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Laboratorio Reig Jofre SA?
As of the previous close price of €2.92, shares in Laboratorio Reig Jofre SA had a market capitalisation of €233.77m.
Where are Laboratorio Reig Jofre SA shares listed?
Here are the trading details for Laboratorio Reig Jofre SA:
- Country of listing: Spain
- Exchange: MCE
- Ticker Symbol: RJF
What kind of share is Laboratorio Reig Jofre SA?
Based on an overall assessment of its quality, value and momentum Laboratorio Reig Jofre SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Laboratorio Reig Jofre SA share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Laboratorio Reig Jofre SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Laboratorio Reig Jofre SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -1.81%.
As of the last closing price of €2.92, shares in Laboratorio Reig Jofre SA were trading +6.87% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Laboratorio Reig Jofre SA PE Ratio?
The Laboratorio Reig Jofre SA PE ratio based on its reported earnings over the past 12 months is 16.26. The shares last closed at €2.92.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Laboratorio Reig Jofre SA?
Laboratorio Reig Jofre SA's management team is headed by:
- Isabel Reig Lopez - CHM
- Ignasi Biosca Reig - CEO
- Alejandro Garcia Reig - VCH
- Roser Gomila Zabala - CFO
- Gabriel Roig Zapatero - COO
- Antonio Ballesteros Gomez - OTH
- Alain Boutboul - OTH
- Ignacio Vila Rocafort - OTH
- Adolf Rousaud Vinas - SEC
- Anton Costas Comesana - IND
- Maria Luisa Francoli Plaza - IND
- Ramon Gomis I de Barbara - IND
- Ramiro Martinez-Pardo del Valle - IND
- Emilio Moraleda Martinez - IND